Details of the Drug Reposition

General Information of This Drug (ID: DM0N9WA)

Drug Name
Calcitonin Human   DM0N9WA
Therapeutic Class
Anticancer Agents
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Paget's disease DISO3MC0 FB85 Approved [1]
------------------------------------------------------------------------------------
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Postmenopausal osteoporosis DISS0RQZ FB83.11 Phase 3 [2]
Pain DIS4RWOW MG30-MG3Z Phase 3 [2]
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial. J Bone Miner Res. 2012 Aug;27(8):1821-9.